Cargando…
How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer
Synthetic glucocorticoids serve as co-medication against solid malignant tumors. However, glucocorticoid receptor activation may promote unsolicited cancer resistance to chemotherapy. The Kang team elucidated a glucocorticoid receptor-centred chemotherapy-resistance mechanism to cisplatin and charac...
Autores principales: | Clarisse, Dorien, De Bosscher, Karolien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367998/ https://www.ncbi.nlm.nih.gov/pubmed/34400619 http://dx.doi.org/10.1038/s41467-021-24847-6 |
Ejemplares similares
-
Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies
por: Clarisse, Dorien, et al.
Publicado: (2018) -
Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies
por: Clarisse, Dorien, et al.
Publicado: (2017) -
Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?
por: Van Moortel, Laura, et al.
Publicado: (2020) -
Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells
por: Clarisse, Dorien, et al.
Publicado: (2023) -
The Biologist’s Guide to the Glucocorticoid Receptor’s Structure
por: Deploey, Nick, et al.
Publicado: (2023)